References
- American Cancer Society. Cancer facts and figures (2009). Atlanta: American Cancer Society.
- American Joint Committee on Cancer (2002). AJCC Cancer Staging Manual: In Extrahepatic bile ducts. 6th ed. New York: Springer.
- Anderson BB, Ukah F, Tette A, et al (1992). Primary tumors of the liver. J National Med Assoc, 84, 129-35.
- Bhudhisawasdi V (1997). Place of surgery in opisthorchiasis associated cholangiocarcinoma. Southeast Asian J Trop Med Public Hlth, 28, 85-90.
- Cancer Unit, Srinagarind Hospital (2010). Hospital-based tumor registry 2009: statistical report. Khon Kaen: Faculty of Medicine, Khon Kaen University.
- Fuller CD, Wang SJ, Choi M, et al (2009). Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population based analysis. PMC, 115, 5175-83.
- Jarnagin WR, Bowne W, Klimstra DS, et al (2005). Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg, 241, 703-14. https://doi.org/10.1097/01.sla.0000160817.94472.fd
- Khuhaprema T, Srivatranakul P, Attasara P, et al editors (2010). Cancer in Thailand: Vol. V, 2001-2003. Bangkok: Bangkok Medical Publisher.
- Khuntikeo N, Phugkhem A, Bhudhisawasdi V, et al (2008). Major hepatic resection for hilar cholangiocarcinoma without preoperative biliary drainage. Asian Pac J Cancer Prev, 9, 83-5.
- Kosuge T, Yamamoto J, Shimada K, et al (1999). Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg, 230, 663-71. https://doi.org/10.1097/00000658-199911000-00008
- Li H, Qin Y, Cui Y, et al (2011). Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: A Chinese experience. Dig Surg, 28, 226-31. https://doi.org/10.1159/000327361
- Murakami Y, Uemura K, Sudo T, et al (2011). Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol, 18, 651-8. https://doi.org/10.1245/s10434-010-1325-4
- Neuhaus P, Jonas S, Bechstein WO, et al (1999). Extended resection for hilar cholangiocarcinoma. Ann Surg, 230, 808-19. https://doi.org/10.1097/00000658-199912000-00010
- Ohtsuka M, Ito H, Kimura F, et al (2003). Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepato-Biliary-Pancreatic Surg, 10, 259-64. https://doi.org/10.1007/s00534-002-0724-8
- Poomphakwaen K, Promthet S, Kamsa-ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand : a nested case-control study. Asian Pac J Cancer Prev, 10, 251-8.
- Shi QF, Liang TB, Qin YS, et al (2007). Evaluation of surgical approach for extrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int, 6, 622-6.
- Sriamporn S, Black R, Sankaranarayanan R, et al (1995). Cancer survival in Khon Kaen Province, Thailand. Int J Cancer, 61, 296-300. https://doi.org/10.1002/ijc.2910610303
- Sripa B, Brindley PJ, Mulvenna J, et al (2012). The tumorigenic liver fluke Opisthorchis viverrrini ? multiple pathways to cancer. Trends Parasitol, 28, 395-407. https://doi.org/10.1016/j.pt.2012.07.006
- Sriplung H, Sontipong S, Martin N, et al (2005). Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev, 6, 276-81.
- Sriplung H, Wiangnon S, Sontipong S, et al (2006). Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev, 7, 239-44.
- StataCorp LP (2007). Stata Release 10: User's guide. College Station TX: Stata Press.
- Unno M, Katayose Y, Rikiyama T, et al (2010). Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 17, 463-9. https://doi.org/10.1007/s00534-009-0206-3
- Uttaravichien T, Bhudhisawasdi V, Pairojkul C, et al (1999). Intrahepatic cholangiocarcinoma in Thailand. J Hepato- Biliary-Pancreatic Surg, 6, 128-35. https://doi.org/10.1007/s005340050095
- Vatanasapt V, Martin N, Sriplung H, et al (1995). Cancer incidence in Thailand 1988-1991. Cancer Epidemiol, Biomarkers and Prev, 4, 475-83.
- Witzigmann H, Berr F, Ringel U, et al (2006). Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma. Ann Surg, 244, 230-9. https://doi.org/10.1097/01.sla.0000217639.10331.47
- Yubin L, Chihua F, Zhixiang J, et al (2008). Surgical management and prognostic factors of hilar cholangiocarcinoma: Experience with 115 cases in China. Ann Surg Oncol, 15, 2113-9. https://doi.org/10.1245/s10434-008-9932-z
Cited by
- Factors Affecting Survival Time of Cholangiocarcinoma Patients: A Prospective Study in Northeast Thailand vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1623
- Survival Analysis of Biliary Tract Cancer Cases in Turkey vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6025
- Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience vol.21, pp.8, 2014, https://doi.org/10.1002/jhbp.74
- Plasma Autoantibodies against Heat Shock Protein 70, Enolase 1 and Ribonuclease/Angiogenin Inhibitor 1 as Potential Biomarkers for Cholangiocarcinoma vol.9, pp.7, 2014, https://doi.org/10.1371/journal.pone.0103259
- Expression of Lamininγ2 in Extrahepatic Cholangiocarcinoma Tissues and its Influence on Tumor Invasion and Metastasis vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2099
- Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy vol.5, pp.6, 2016, https://doi.org/10.3892/mco.2016.1072
- Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor vol.2, pp.6, 2014, https://doi.org/10.3892/mco.2014.377
- A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand vol.10, pp.1, 2016, https://doi.org/10.1371/journal.pntd.0004293
- A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma vol.13, pp.5, 2017, https://doi.org/10.3892/ol.2017.5847
- Cohort profile: cholangiocarcinoma screening and care program (CASCAP) vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-1475-7